Temozolomide 140 MG Oral Capsule [Temodar] — RxCUI 705617
RxNorm drug concept · Semantic branded drug
RxCUI 705617
Semantic branded drug · SBD
● Current RxNorm concept 7 FDA products
12 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI705617
Official nameTemozolomide 140 MG Oral Capsule [Temodar]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTemodar 140 MG Oral Capsule
FDA products mapped7
Package NDCs mapped12
Reported Medicaid activity (SDUD)330 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Temozolomide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Temozolomide is a chemotherapy used to treat aggressive brain tumors — specifically glioblastoma (a fast-growing brain tumor) and anaplastic astrocytoma. It works by getting into c...
- What exactly is temozolomide treating, and why do I need it?
- Yes, it does matter. Swallow the capsules whole with a full glass of water — never open, crush, or chew them. Try to avoid taking them right after a high-fat meal, because fat can...
- How should I take the capsules — does it matter when I take them or whether I eat first?
🕸️ Concept Web — How Temozolomide 140 MG Oral Capsule [Temodar] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Temozolomide 140 MG Oral Capsule [Temodar]
RxCUI 705617 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Temozolomide
37776IN
-
Temozolomide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Temodar
261663BN
-
Temodar
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Temozolomide Oral Capsule
374610SCDF -
Temozolomide Oral Product
1161486SCDG -
Temozolomide Pill
1161487SCDG -
Temozolomide Oral Capsule [Temodar]
366431SBDF -
Temodar Oral Product
1181414SBDG -
Temodar Pill
1181415SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Temozolomide Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Temozolomide 140 MG Oral Capsule
700883SCD -
Temozolomide 140 MG
700882SCDC -
Temozolomide 140 MG [Temodar]
705616SBDC
-
Temozolomide 140 MG Oral Capsule
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Temozolomide 140 MG Oral Capsule
SCD · 700883 -
Temozolomide 140 MG
SCDC · 700882 -
Temozolomide Oral Capsule
SCDF · 374610 -
Temozolomide Oral Product
SCDG · 1161486 -
Temozolomide Pill
SCDG · 1161487
Brand-Name Concepts
-
Temozolomide 140 MG [Temodar]
SBDC · 705616 -
Temozolomide Oral Capsule [Temodar]
SBDF · 366431 -
Temodar Oral Product
SBDG · 1181414 -
Temodar Pill
SBDG · 1181415 -
Temodar
BN · 261663
📦 FDA Products & Package NDCs
7 products · 12 package NDCs
12 package NDCs map to RxCUI 705617 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00085-1366-03 | 5 PACKET in 1 CARTON (0085-1366-03) / 1 CAPSULE in 1 PACKET... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1366-04 | 14 PACKET in 1 CARTON (0085-1366-04) / 1 CAPSULE in 1 PACKE... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1381-01 | 1 VIAL, SINGLE-USE in 1 CARTON (0085-1381-01) / 40 mL in 1... | TEMODAR | Merck Sharp & Dohme LLC | 2009-02-27 |
| 00085-1417-02 | 5 PACKET in 1 CARTON (0085-1417-02) / 1 CAPSULE in 1 PACKET... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1425-03 | 5 PACKET in 1 CARTON (0085-1425-03) / 1 CAPSULE in 1 PACKET... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1425-04 | 14 PACKET in 1 CARTON (0085-1425-04) / 1 CAPSULE in 1 PACKE... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1430-03 | 5 PACKET in 1 CARTON (0085-1430-03) / 1 CAPSULE in 1 PACKET... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1430-04 | 14 PACKET in 1 CARTON (0085-1430-04) / 1 CAPSULE in 1 PACKE... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1519-03 | 5 PACKET in 1 CARTON (0085-1519-03) / 1 CAPSULE in 1 PACKET... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-1519-04 | 14 PACKET in 1 CARTON (0085-1519-04) / 1 CAPSULE in 1 PACKE... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-3004-03 | 5 PACKET in 1 CARTON (0085-3004-03) / 1 CAPSULE in 1 PACKET... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
| 00085-3004-04 | 14 PACKET in 1 CARTON (0085-3004-04) / 1 CAPSULE in 1 PACKE... | TEMODAR | Merck Sharp & Dohme LLC | 1999-08-11 |
Observed labelers:
Merck Sharp & Dohme LLC (12)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9328 | Temozolomide injection | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.